Cipro Plaintiffs, Defendants Bear Their Own Costs of §1 Litigation

Plaintiffs who suffered dismissal of their claims that a reverse payment settlement by makers of the antibiotic ciprofloxacin hydrochloride succeed in convincing the U.S. District Court for the Eastern District of New York to vacate an award of costs imposed upon them because the litigation was sufficiently close, complex, and protracted (In re Ciprofloxin Hydrochloride Antitrust Litigation, E.D.N.Y.).

Judge Frederic Block explains that, in In re Ciprofloxcin Hydrochloride Antitrust Litigation, 363 F.Supp.2d 514 (E.D.N.Y. 2005) (Cipro I), the court granted the summary judgment motions filed by the defendants, which manufacture the antibiotic ciprofloxacin hydrochloride.

Later ...